— Know what they know.
Not Investment Advice

CJJD NASDAQ

China Jo-Jo Drugstores, Inc.
1W: +12.6% 1M: -34.8% 3M: -44.7% 1Y: -67.4% 3Y: -98.7% 5Y: -99.7%
$1.52
Last traded 2025-03-31 — delisted
NASDAQ · Healthcare · Medical - Pharmaceuticals · $9.9M mcap · 4M float · 10.71% daily turnover

Balance Sheet Trends

Total Assets
$95M +4.5% ▲
5Y CAGR: +5.5%
Total Liabilities
$81M +8.7% ▲
5Y CAGR: +7.7%
Shareholders Equity
$16M -13.2% ▼
5Y CAGR: -2.9%
Cash & Investments
$20M +7.1% ▲
5Y CAGR: +16.2%
Total Debt
$43M +2.5% ▲
5Y CAGR: +10.7%
Net Debt
$23M -1.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$16M$22M$18M$19M$20M
Short-Term Investments$157K$91K$95K$0$0
Cash & ST Investments$16M$22M$19M$19M$20M
Net Receivables$15M$19M$23M$17M$19M
Inventory$12M$17M$16M$15M$17M
Other Current Assets$164K$13M$77K$13M$13M
Total Current Assets$61M$72M$75M$64M$70M
Property, Plant & Equip.$29M$23M$20M$19M$19M
Goodwill & Intangibles$4M$4M$4M$3M$4M
Long-Term Investments$3M$4M$4M$2M$1M
Other Non-Current Assets$795K$2M$3M$1M$2M
Total Non-Current Assets$39M$34M$31M$26M$25M
Total Assets$100M$106M$106M$91M$95M
— Liabilities —
Accounts Payable$22M$30M$27M$27M$32M
Short-Term Debt$30M$29M$39M$29M$32M
Deferred Revenue$708K$1M$2M$696K$518K
Other Current Liabilities$6M$7M$1M$4M$10M
Total Current Liabilities$57M$65M$74M$67M$74M
Long-Term Debt$4M$2M$9M$0$0
Other Non-Current Liab.$135K$0-$9M$0$0
Total Non-Current Liabilities$23M$17M$9M$8M$6M
Total Liabilities$81M$82M$84M$74M$81M
— Equity —
Common Stock$33K$42K$42K$284K$418K
Retained Earnings-$36M-$45M-$48M-$69M-$74M
Accumulated OCI$3M$4M$6M$3M$2M
Total Stockholders Equity$21M$26M$24M$18M$16M
Total Liabilities & Equity$100M$106M$106M$91M$95M
— Key Metrics —
Total Debt$54M$47M$49M$42M$43M
Net Debt$38M$25M$30M$23M$23M
Total Investments$3M$4M$5M$2M$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms